Group One Trading’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3
| Closed | -$54 | – | 8524 |
|
|
2026
Q1 | $54 | Sell |
3
-754
| -100% | -$16.6K | ﹤0.01% | 7448 |
|
|
2025
Q4 | $18K | Sell |
757
-196
| -21% | -$5.78K | ﹤0.01% | 6423 |
|
|
2025
Q3 | $29.7K | Buy |
953
+936
| +5,506% | +$29.5K | ﹤0.01% | 6377 |
|
|
2025
Q2 | $332 | Sell |
17
-3
| -15% | -$60 | ﹤0.01% | 7699 |
|
|
2025
Q1 | $342 | Sell |
20
-140
| -88% | -$3.31K | ﹤0.01% | 7330 |
|
|
2024
Q4 | $4.22K | Buy |
160
+20
| +14% | +$802 | ﹤0.01% | 6480 |
|
|
2024
Q3 | $4.62K | Buy |
+140
| New | +$9.46K | ﹤0.01% | 5908 |
|
|
2023
Q1 | – | Sell |
-10
| Closed | -$1.49K | – | 7979 |
|
|
2022
Q4 | $1.49K | Sell |
10
-3
| -23% | -$545 | ﹤0.01% | 6740 |
|
|
2022
Q3 | $2K | Buy |
13
+10
| +333% | +$1.93K | ﹤0.01% | 7211 |
|
|
2022
Q2 | $1K | Sell |
3
-16
| -84% | -$2.93K | ﹤0.01% | 7630 |
|
|
2022
Q1 | $3K | Sell |
19
-29
| -60% | -$5.01K | ﹤0.01% | 7655 |
|
|
2021
Q4 | $10K | Sell |
48
-26
| -35% | -$7.37K | ﹤0.01% | 7359 |
|
|
2021
Q3 | $24K | Buy |
74
+7
| +10% | +$2.46K | ﹤0.01% | 7072 |
|
|
2021
Q2 | $30K | Buy |
67
+48
| +253% | +$24K | ﹤0.01% | 6959 |
|
|
2021
Q1 | $11K | Sell |
19
-21
| -53% | -$15.1K | ﹤0.01% | 7025 |
|
|
2020
Q4 | $23K | Buy |
40
+37
| +1,233% | +$18.4K | ﹤0.01% | 5451 |
|
|
2020
Q3 | $1K | Sell |
3
-110
| -97% | -$38.2K | ﹤0.01% | 5964 |
|
|
2020
Q2 | $37K | Buy |
+113
| New | +$25.8K | ﹤0.01% | 4541 |
|
|
2016
Q4 | – | Sell |
-1
| Closed | -$3K | – | 4853 |
|
|
2016
Q3 | $3K | Hold |
1
| – | – | ﹤0.01% | 4323 |
|
|
2016
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 4523 |
|
|
2016
Q1 | $1K | Buy |
+1
| New | +$1.59K | ﹤0.01% | 4456 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$2K | – | 5199 |
|
|
2015
Q2 | $2K | Sell |
1
-6
| -86% | -$15.6K | ﹤0.01% | 4678 |
|
|
2015
Q1 | $21K | Sell |
7
-100
| -93% | -$277K | ﹤0.01% | 3861 |
|
|
2014
Q4 | $282K | Buy |
107
+60
| +128% | +$155K | ﹤0.01% | 2020 |
|
|
2014
Q3 | $130K | Buy |
47
+20
| +74% | +$65K | ﹤0.01% | 2768 |
|
|
2014
Q2 | $94K | Sell |
27
-4
| -13% | -$14.2K | ﹤0.01% | 3049 |
|
|
2014
Q1 | $114K | Sell |
31
-42
| -58% | -$165K | ﹤0.01% | 2958 |
|
|
2013
Q4 | $277K | Buy |
73
+24
| +49% | +$86.4K | ﹤0.01% | 2148 |
|
|
2013
Q3 | $161K | Buy |
+49
| New | +$143K | ﹤0.01% | 2572 |
|
Other funds holding TRIB
HAIM
WN
MAWA
IWA
BCM
Group One Trading's TRIB Position: Q4 2023 in Review
Group One Trading sold out of Trinity Biotech (TRIB) in Q4 2023, closing a stake of 111 shares — an estimated $12.2K sold.
Group One Trading first reported a position in TRIB in Q2 2013 and held it in 18 quarters. The position peaked at $1.15M in Q4 2013. 24 funds tracked by Wall St. Rank hold TRIB as of Q4 2023.
- Group One Trading reported no remaining Trinity Biotech position as of Q4 2023 after selling out during the quarter.
- Group One Trading sold 111 Trinity Biotech shares in Q4 2023, an estimated $12.2K.
- Group One Trading first reported a position in Trinity Biotech in Q2 2013 and held it in 18 quarters.
- Group One Trading's Trinity Biotech position peaked at $1.15M in Q4 2013.
- 24 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2023.
Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.